Partnership accelerates AGC Biologics' leadership in the AAV market, applying its BravoAAV™ platform to complex gene therapies for inherited blindness MILAN--(BUSINESS WIRE)-- On the heels of ...
New research shows potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector This study describes the discovery, ...
Patients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 gangliosidosis, which includes Tay-Sachs and Sandhoff diseases, exhibited a ...
Although the integration of lentiviral vectors has proved to be safe in previous clinical studies of gene therapy, 11 two reports have described clonal expansions related to lentiviral vector ...
PARIS, France (September 12, 2024) - Genethon, the pioneering French laboratory and leader in the research and development of gene therapies for rare diseases, announced today publication in Nature ...
Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results